Home / La Revue Dafee/ Why does your cholesterol number tell you so little?
Why does your cholesterol number tell you so little?
Why does your cholesterol number tell you so little?
Your total cholesterol number tells you so little because it aggregates LDL, HDL, and triglyceride-derived cholesterol into a single value — without revealing how that total is distributed. Two people can share an identical total cholesterol reading while having radically different cardiovascular risk profiles, depending on the ratio between their markers.
This is not medicine failing. It is medicine doing what it was designed to do at scale: take a complex biological signal, reduce it to something actionable, and apply it uniformly across millions of patients. The problem is not the intention. The problem is that the number was never designed to capture what is actually happening in your lipid system — and we have been using it as though it does for sixty years.
Where did the cholesterol number come from?
The cholesterol threshold originated from Ancel Keys' epidemiological work in the 1950s-60s, which linked elevated serum cholesterol to cardiovascular mortality at a population level. Total cholesterol became the standard clinical metric because it was simple, reproducible, and cheap to measure — not because it was the most biologically meaningful marker. Its threshold, initially 240 mg/dL, was derived from population distributions rather than individual mechanistic understanding.
What that logic required was a single, measurable number. Total cholesterol was that number — the sum of all cholesterol carried in the bloodstream, regardless of which lipoprotein is carrying it, in which direction, or for what purpose. It was a practical choice, not a biological one. The assay was simple, reproducible, and cheap. The threshold — initially 240 mg/dL, later revised — was derived from population distributions, not from a mechanistic understanding of when cholesterol becomes pathological.
The number worked well enough at the extremes. Severe hypercholesterolaemia is genuinely dangerous. Total cholesterol in the 99th percentile does predict elevated cardiovascular risk. But for the vast majority of people — those in the middle of the distribution, where clinical decisions are most consequential — total cholesterol alone is a remarkably poor predictor of individual outcome.
What does total cholesterol actually measure?
Total cholesterol measures the aggregate concentration of cholesterol molecules in the blood, regardless of context. It does not distinguish between LDL cholesterol being transported to peripheral tissues and HDL cholesterol being returned to the liver for processing. It does not capture particle size, particle number, or the oxidative state of the lipoproteins involved. It does not reflect triglyceride levels, which are independently relevant to metabolic risk. It does not account for the ratio between these markers — which is where most of the predictive signal actually lives.
To understand why this matters, consider two people with identical total cholesterol readings of 200 mg/dL. One has HDL of 70 mg/dL and LDL of 110 mg/dL — a profile that most lipid specialists would consider metabolically healthy. The other has HDL of 35 mg/dL and LDL of 145 mg/dL — a profile associated with significantly elevated cardiovascular risk. The total cholesterol number cannot distinguish them. They receive the same verdict from the same test.
This is not a marginal edge case. It is the norm. The distribution of cholesterol across lipoprotein fractions varies enormously between individuals with similar total cholesterol, and that distribution carries most of the clinically relevant information.
Why does the ratio between lipid markers matter more than the number?
The ratio between lipid markers matters more than total cholesterol because it reveals function, not just quantity. The total cholesterol/HDL ratio — sometimes called the atherogenic index — has outperformed total cholesterol alone in multiple large prospective studies for predicting cardiovascular events, because it reflects how actively the body's reverse cholesterol transport system is functioning.
Similarly, the ratio of triglycerides to HDL — sometimes used as a proxy for insulin resistance and small dense LDL particle concentration — carries predictive information that total cholesterol simply cannot provide. Elevated triglycerides in the context of low HDL is a pattern associated with metabolic syndrome, independent of total cholesterol levels.
LDL itself is more complex than the standard lipid panel reveals. LDL cholesterol as typically reported is a calculated value — derived from total cholesterol, HDL, and triglycerides using the Friedewald equation — not a direct measurement. More importantly, LDL is not a homogeneous entity. Small dense LDL particles are considerably more atherogenic than large buoyant LDL particles. Two individuals can have identical LDL cholesterol values while carrying vastly different particle distributions and therefore vastly different metabolic risk profiles.
None of this is captured by a single total cholesterol number.
What would a more complete reading of a lipid panel look like?
A complete reading of a lipid panel uses pattern recognition rather than threshold comparison — asking what the relationship between markers reveals, not whether each value is above or below a cutoff. The standard panel already reports total cholesterol, LDL, HDL, and triglycerides; from these four values, the triglyceride/HDL ratio, the total cholesterol/HDL ratio, and the likely LDL particle size can all be inferred without ordering additional tests.
The key is pattern recognition rather than threshold comparison. Instead of asking "is this number above or below a cutoff?", the relevant questions are: What is the relationship between these markers? What does the triglyceride/HDL ratio suggest about insulin sensitivity? What does the total cholesterol/HDL ratio suggest about reverse transport efficiency? Is the LDL elevation accompanied by low triglycerides — suggesting large buoyant particles — or high triglycerides, suggesting the small dense variant?
These questions do not require additional tests. They require a different interpretive framework applied to existing data. The panel most people already have, read differently, tells a substantially richer story about metabolic function than the single number they are given.
This is not to suggest that total cholesterol is useless — it is a reasonable first filter, and in the context of genetic hypercholesterolaemia, it remains clinically important. But for the majority of adults reviewing a standard lipid panel, the number alone is the beginning of a question, not the answer to one.
Is there a better way to interpret metabolic risk?
Yes — emerging approaches to lipid interpretation emphasise pattern classification over threshold comparison, identifying complete metabolic profiles rather than flagging individual values in isolation. This reflects the biological reality that lipid metabolism is a system: markers interact, and the relationships between them carry more clinical meaning than any single value read alone.
The practical implication is that the same blood test most people already take — the standard lipid panel ordered by a general practitioner — contains substantially more information than is typically extracted from it. Reading it well is not a matter of access to more data. It is a matter of interpretive framework.
Written by the Dafee Science Team — published 29/04/2026. Dafeepédia content is developed from European regulatory sources (EFSA, EC Regulation 432/2012) and peer-reviewed scientific literature, and reviewed for accuracy before publication.
The Dafee Metabolic Intelligence app interprets standard lipid blood panels as metabolic patterns rather than isolated thresholds — available at app.dafee.fr.